Cita APA (7th ed.)

Hogarty, M. D., Ziegler, D. S., Franson, A., Chi, Y., Tsao‐Wei, D., Liu, K., . . . Marachelian, A. (2024). Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy trial.

Cita Chicago (17th ed.)

Hogarty, Michael D., et al. Phase 1 Study of High-dose DFMO, Celecoxib, Cyclophosphamide and Topotecan for Patients with Relapsed Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. 2024.

Cita MLA (9th ed.)

Hogarty, Michael D., et al. Phase 1 Study of High-dose DFMO, Celecoxib, Cyclophosphamide and Topotecan for Patients with Relapsed Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. 2024.